Cargando…

Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells

Objective: Increasing evidence highlights antisense long non-coding RNAs (lncRNAs) as promising therapeutic targets for cancers. Herein, this study focused on the clinical implications and functions of a novel antisense lncRNA PRKAG2-AS1 in hepatocellular carcinoma (HCC). Methods: PRKAG2-AS1 express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Yanjiao, Deng, Yong, Wang, Hong, Zhang, Qingyi, Luo, Huan, Hu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076551/ https://www.ncbi.nlm.nih.gov/pubmed/33928106 http://dx.doi.org/10.3389/fmed.2021.649279

Ejemplares similares

Radiosynthesis of a novel antisense imaging probe targeting LncRNA HOTAIR in malignant glioma
por: Ren, Jiongyu, et al.
Publicado: (2022)

Cardiomiopatia PRKAG2
por: Sternick, Eduardo Back
Publicado: (2022)

Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma
por: Chen, Jieqing, et al.
Publicado: (2021)

LncRNA as a Therapeutic Target for Angiogenesis
por: Kumar, Mohan M., et al.
Publicado: (2017)

LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis
por: Wang, Qing-fang, et al.
Publicado: (2021)

Cardiac manifestations of PRKAG2 mutation
por: Banankhah, Pooya, et al.
Publicado: (2018)

Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG
por: Song, Xiao-Wei, et al.
Publicado: (2023)

Expansion of antisense lncRNA transcriptomes since the loss of RNAi
por: Alcid, Eric A., et al.
Publicado: (2016)

Antisense lncRNA CHROMR is linked to glioma patient survival
por: Širvinskas, Dovydas, et al.
Publicado: (2023)

Targeting LncRNA LLNLR-299G3.1 with antisense oligonucleotide inhibits malignancy of esophageal squamous cell carcinoma cells in vitro and in vivo
por: TIAN, LI, et al.
Publicado: (2023)

LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
por: Xiao, Yuhang, et al.
Publicado: (2020)

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma
por: Deng, Yan, et al.
Publicado: (2021)

Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition
por: Pian, Lingling, et al.
Publicado: (2018)

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2020)

Identification of a KIR antisense lncRNA expressed by progenitor cells
por: Wright, Paul W., et al.
Publicado: (2013)

Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling
por: Chen, Shaojie, et al.
Publicado: (2022)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma
por: Mosca, Nicola, et al.
Publicado: (2023)

Focando no Ventrículo Direito na Síndrome PRKAG2
Publicado: (2022)

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2018)

Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma
por: Luo, Tao, et al.
Publicado: (2019)

Bases of antisense lncRNA-associated regulation of gene expression in fission yeast
por: Wery, Maxime, et al.
Publicado: (2018)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma
por: Cao, Xinghua, et al.
Publicado: (2021)

LncRNA‐422 suppresses the proliferation and growth of colorectal cancer cells by targeting SFPQ
por: Meng, Yixuan, et al.
Publicado: (2022)

lncRNA LOC100911717-targeting GAP43-mediated sympathetic remodeling after myocardial infarction in rats
por: Li, Pingjiang, et al.
Publicado: (2023)

Development and Verification of an Autophagy-Related lncRNA Signature to Predict Clinical Outcomes and Therapeutic Responses in Ovarian Cancer
por: Li, Yan, et al.
Publicado: (2021)

Microinjection of antisense oligonucleotides into living mouse testis enables lncRNA function study
por: Chen, Zhaohui, et al.
Publicado: (2021)

An antisense intragenic lncRNA SEAIRa mediates transcriptional and epigenetic repression of SERRATE in Arabidopsis
por: Chen, Wei, et al.
Publicado: (2023)

SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
por: Tamang, Suraksha, et al.
Publicado: (2019)

LncRNA HOTAIR: A Potential Prognostic Factor and Therapeutic Target in Human Cancers
por: Xin, Xiaoru, et al.
Publicado: (2021)

LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers
por: Yuan, Xin, et al.
Publicado: (2022)

LncRNA Rik-203 Contributes to Sevoflurane Induced Neurotoxicity?
por: Zhang, Lei, et al.
Publicado: (2020)

LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer
por: Zhang, Yunxiang, et al.
Publicado: (2023)

Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations
por: Pöyhönen, Pauli, et al.
Publicado: (2015)

Left ventricular non-compaction cardiomyopathy associated with the PRKAG2 mutation
por: Zhang, Jing, et al.
Publicado: (2022)

LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
por: Cheng, Di, et al.
Publicado: (2018)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

Natural antisense RNA promotes 3′ end processing and maturation of MALAT1 lncRNA
por: Zong, Xinying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hbfn7u5vm8h323kc28n2l9feqg